New chiral P,N-hybrid aryl phosphites have been obtained by one-step phosphorylation of amino and imino alcohols. Complexation of the new ligands with [Rh(CO) 2 Cl] 2 , [Pd(COD)Cl 2 ] and [Pd(allyl)Cl] 2 was found to give chelate complexes [Rh(CO)Cl(η 2 -P ʝ N)], [PdCl 2 (η 2 -P ʝ N)] and [Pd-(allyl)(η 2 -P ʝ N)] + Cl − , respectively. With these new P,N-ligands, up to 82% ee enantioselectivity was achieved in the [a] The new P,N-bidentate aryl phosphites were synthesized by one-step phosphorylation of the corresponding amino and imino alcohols with bis(2,6-dimethylphenyl) chlorophosphite.They divide into two groups: ligands 3aϪ3f, possessing sp 3 -hybridized nitrogen atoms, and ligands 3gϪ3m, which have sp 2 -hybridized nitrogen atoms. All the compounds 3aϪm are soluble in conventional organic solvents and stable under dry conditions for several months. On treatment with [Rh(CO) 2 Cl] 2 , their neutral carbonyl(chloro)Rh I complexes were obtained.The ν(CO) and 1 J P,Rh parameters in their IR and 31 P NMR spectra act as sensitive indicators, which characterise the mode of complexation of the P,N-ligands and allow the π-acceptor ability of the phosphorus centre and the degree of electronic non-symmetry of the ligands to be estimated. [13Ϫ15] In general, ligands 3aϪ3m give chelate complexes. Thus, the
2002 organo-phosphorus compounds organo-phosphorus compounds S 0080 39 -178 Pd-Catalyzed Asymmetric Allylation of an o-Carborane Derivative. -The asymmetric synthesis of 2-phenyl-2-(2-phenyl-o-carboran-1-yl)pent-4enoate by palladium-catalyzed allylation in the presence of amino phosphites as chiral ligands is presented. -(LEBEDEV, R. V.; MOISEEV, S. K.; BONDAREV, O. G.; IL'IN, M. M.; GAVRILOV, K. N.; KALININ, V. N.; Russ.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.